API
< Back to all clusters
[BUSINESS] · Egypt · 2 sources

started · updated

Egyptian Drug Authority and East Pharma discuss localizing pharmaceutical manufacturing

Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority, met with representatives from East Pharma, led by Global Executive Chairman and CEO Philip Haas, to discuss enhancing investments in Egypt's pharmaceutical sector. The discussions focused on expanding local manufacturing, transferring modern technology, and developing production and research capabilities to support Egypt's efforts in localizing the drug industry and strengthening pharmaceutical security.

During the meeting, Philip Haas outlined the company's investment directions and expansion plans for the Egyptian market over the coming years. The talks included reviewing current investments and future plans to expand production lines, with a specific focus on developing complex pharmaceutical products and enhancing local research and development capabilities.

Both parties explored mechanisms to facilitate the availability of priority medicines in the Egyptian market while adhering to regulatory frameworks and intellectual property rights. This initiative aligns with the Egyptian Drug Authority's strategy to attract qualitative investments and increase the competitiveness and export capacity of the Egyptian pharmaceutical industry.

Entities

Ali El-Ghamrawy · East Pharma · Egypt · Egyptian Drug Authority · Philip Haas